Safety and efficacy of transitioning inflammatory bowel disease patients from intravenous to subcutaneous infliximab: a single-center real-world experience

将炎症性肠病患者从静脉注射英夫利昔单抗过渡到皮下注射英夫利昔单抗的安全性和有效性：一项单中心真实世界经验